Cohance Lifesciences shares climb as CRISIL assigns Stable rating
Why did Cohance Lifesciences Ltd shares fall today?
Cohance Lifesciences Ltd shares saw a minor decline today, falling 0.39% to ₹442.75 as of Thursday, 2:53 PM. The movement appears to be linked to a regulatory filing the company made regarding a change in its credit ratings.
In the filing, Cohance Lifesciences informed stock exchanges that, at its own request, CRISIL Ratings Limited has withdrawn the credit ratings it had assigned to certain lower-limit facilities of the company. This means the independent rating agency is no longer providing a rating for those specific, smaller borrowing limits.
The company clarified that this withdrawal has no real negative impact. It explained that these lower-limit facilities are already adequately covered under the existing credit ratings assigned by another agency, India Ratings and Research Private Limited, for the company's larger, higher-limit credit facilities. Therefore, the company's overall borrowing arrangements and existing credit facilities remain unaffected, and the ratings from India Ratings are still valid and in force.
What does Cohance Lifesciences Ltd do?
Cohance Lifesciences Ltd is a company that maintains credit ratings from India Ratings and Research Private Limited for its higher-limit credit facilities. The company operates with existing credit facilities and borrowing arrangements.
The company's credit facilities are adequately covered by the ratings from India Ratings, and these ratings remain valid and in force. Any withdrawal of other ratings does not impact the company's existing credit facilities or borrowing arrangements.
Cohance Lifesciences Ltd Financials
In CroresCohance Lifesciences Ltd reported a revenue of ₹619.12 Crores in March 2026, which declined by approximately 31.8% to ₹422.26 Crores in June 2026. On the profitability front, the company posted a net profit of ₹19.55 Crores in March 2026, but swung to a net loss of ₹24.12 Crores in June 2026, reflecting a deterioration of ₹43.67 Crores. The financial data indicates a downward trend in both revenue and profitability between the two reported quarters, with the company shifting from a profitable position to a loss-making one, suggesting potential operational or market headwinds during this period.
Cohance Lifesciences Ltd Shareholding Pattern
Promoter holding stands at 57.49% of the total share capital. Foreign Institutional Investors (FIIs) hold 6.5% stake in the company, while Domestic Institutional Investors (DIIs) hold 20.09%. Public shareholders hold the remaining 15.93% stake in Cohance Lifesciences Ltd.
Cohance Lifesciences Ltd FAQs
Q: Why did Cohance shares fall 0.39% today?
Credit Rating. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Cohance Lifesciences Ltd?
As per the latest data, promoters hold 57.49% stake in Cohance Lifesciences Ltd, while FII holding stands at 6.5%. Domestic institutional investors hold 20.09%, and public shareholders account for 15.93% of the equity.
Q: What is the current stock price of Cohance Lifesciences Ltd?
Cohance Lifesciences Ltd shares are currently trading at ₹442.75, recording a decline of 0.39% from the previous close.
Q: What is the market capitalization of Cohance Lifesciences Ltd?
The company currently has a market capitalization of ₹16939.5 crore, reflecting its valuation in the Indian equity market.